Borosil Ltd · NSE:BOROLTD

Borosil — Q4 FY2022 Earnings Presentation

51 slides from Borosil's earnings presentation, May 9, 2022

  1. Slide 1: Exchange intimation of conference call and investor presentation

    Boro■II Limited BOROSIC CN. U&IOOMH2010Pl091722 lwgl,lorod &Ca,panoo Oflb ' 1101,C--.G--81.d.0,.,.MCAOA9-di,,K.r.w111C.,,..., -.ro--400051,lndiL T •91 Z2 67-40 6300 F +912267-40 65 1 ◄ May 09, 2022 w-- E boni~i.bonnll.com BSE Limited National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers

  2. Slide 2: Q4FY22 Results Conference Call

    Borosil Limited Q4FY22 Results Conference Call We co‐ordially invite you for a call with the management of Borosil Ltd to discuss its performance for the quarter and year ended 31st March 2022. Con Call date: Wednesday, 11th May 2022, at 11:00 AM IST Represented by: Mr. Shreevar Kheruka ‐ Managing D

  3. Slide 3: Investor Presentation Q4FY22

    Borosil Limited Investor Presentation Q4FY22 Borosil Investor presentation - Q4FY22 01

  4. Slide 4: Safe Harbour Statement

    Safe Harbour Statement “ This investor presentation has been prepared by Borosil Limited (”Borosil” or “Company”) on a strictly con dential basis. Certain statements in this presentation may be ‘forward looking statements’ within the meaning of applicable laws and regulations. These forward looking

  5. Slide 5: About Borosil

    About Borosil Brand with a 50+ year legacy Enjoys strong consumer equity in serving-ware, kitchen appliances and storage National leader in laboratory glassware Borosil Investor presentation - Q4FY22 03

  6. Slide 6: Vision

    Vision To be the most customer-centric company in India Offer products that perform beautifully Develop innovative products to meet evolving customer needs Be a dependable partner that creates value for customers Nurture long-term relationships with all stakeholders Borosil Investor presentation - Q4

  7. Slide 7: Re-Imagining Consumer Products Division

    Re-Imagining Consumer Products Division Glass Products Consumer Brands Company Company Daily Use Occasional Use (Serving ware, Storage, (Microwavable) Appliances) Single Brand Adding Brands BOROSIL BOROSIL, LARAH General Trade General Trade Modern Trade E-Commerce Borosil Investor presentation - Q4F

  8. Slide 8: Re-Imagining Scientific Products Division

    Re-Imagining Scienti c Products Division Single Brand Three Brands BOROSIL BOROSIL, LabQuest, Klasspack Lab Glassware Lab Glassware Only Lab Instruments Pharma Packaging Domestic Business Domestic Business International Business Borosil Investor presentation - Q4FY22 06

  9. Slide 9: Journey Over Last 5 Years

    Journey Over Last 5 Years Operating SALES CAGR : 18% EBITDA CAGR : 26% 840 155 436 61 2017-18 2021-22 2017-18 2021-22 The gures are in INR Crore Borosil Investor presentation - Q4FY22 07

  10. Slide 10: Financial Overview Q4 FY22 (consolidated)

    Financial Overview Q4 FY22 (consolidated) INR Crore Q4FY20 Q4 FY21 Q4 FY22 Growth % Net Sales 141.8 184.1 220.1 19.6% EBITDA (3.1) 37.9 39.6 4.6% EBITDA (Before exceptional items) (3.1) 37.9 44.4 17.1% EBITDA (%) (2.2)% 20.6% 20.2% EBIT (12.5) 28.6 36.4 27.5% (Before exceptional items) PBT (13.7) 27

  11. Slide 11: Financial Overview FY22 (consolidated)

    Financial Overview FY22 (consolidated) INR Crore FY20 FY21 FY22 Growth % Net Sales 635.9 584.8 839.9 43.6% EBITDA 87.4 99.1 157.0 58.3% EBITDA (Before exceptional items) 87.4 102.7 168.2 63.7% EBITDA (%) 13.7% 17.6% 20.0% EBIT (Before exceptional items) 49.1 67.3 134.3 99.7% PBT 43.6 61.2 122.0 99.2

  12. Slide 12: Financial Overview Q4 FY22 Consumerware Division

    Financial Overview Q4 FY22 Consumerware Division INR Crore Q4 FY20 Q4 FY21 Q4 FY22 Growth % Net Sales 86.4 118.1 137.5 16.5% EBITDA (6.7) 19.6 17.2 (12.2)% EBITDA (Before exceptional items) (6.7) 19.6 19.6 (0.1)% EBITDA (%) (7.8)% 16.6% 14.3% EBIT (Before exceptional items) (11.8) 13.6 14.2 4.4% PBT

  13. Slide 13: Financial Overview FY22 Consumerware Division

    Financial Overview FY22 Consumerware Division INR Crore FY20 FY21 FY22 Growth % Net Sales 434.0 384.8 573.0 48.9% EBITDA 53.6 47.7 88.6 85.8% EBITDA (Before exceptional items) 53.6 49.5 94.2 90.4% EBITDA (%) 12.4% 12.9% 16.4% EBIT 29.5 27.0 71.5 165.1% (Before exceptional items) PBT 26.7 24.0 65.4 1

  14. Slide 14: Category wise sales (Consumerware)

    Category wise sales (Consumerware) INR Crore Q4 Q4 Category FY21 FY22 Growth % FY21 FY22 Growth % Glassware 30.3 37.2 22.9% 102.6 146.0 42.3% Non Glassware 36.0 50.0 38.8% 141.1 207.4 47.0% Opalware 51.8 50.3 (2.9)% 141.1 219.6 55.7% Total Consumerware 118.1 137.5 16.5% 384.8 573.0 48.9% Borosil Inv

  15. Slide 15: Financial Overview Q4 FY22 Scientific Division (Consolidated)

    Financial Overview Q4 FY22 Scienti c Division (Consolidated) INR Crore Q4 FY20 Q4 FY21 Q4 FY22 Growth % Net Sales 55.4 66.0 82.6 25.1% EBITDA 5.5 16.1 20.4 26.5% EBITDA 22.8 41.2% (Before exceptional items) 5.5 16.1 EBITDA (%) 10.0% 24.4% 27.6% EBIT 1.2 12.8 20.1 58.0% (Before exceptional items) PBT

  16. Slide 16: Financial Overview FY22 Scientific Division (Consolidated)

    Financial Overview FY22 Scienti c Division (Consolidated) INR Crore FY20 FY21 FY22 Growth % Net Sales 201.8 200.0 266.9 33.4% EBITDA 32.0 42.2 54.7 29.8% EBITDA 37.3% (Before exceptional items) 32.0 44.0 60.4 EBITDA (%) 15.9% 22.0% 22.6% EBIT 17.9 31.0 49.2 58.7% (Before exceptional items) PBT 15.1

  17. Slide 17: Category wise sales (Scientific)

    Category wise sales (Scienti c) INR Crore Q4 Q4 Category FY21 FY22 Growth % FY21 FY22 Growth % Laboratory Glassware 44.3 52.4 18.3% 126.5 156.2 23.4% Lab Instrumentation 5.7 7.9 38.6% 15.9 21.3 33.6% Pharma Packaging 16.0 22.2 39.1% 57.5 89.5 55.5% Total Scienti c 66.0 82.6 25.1% 200.0 266.9 33.4% B

  18. Slide 18: ROCE (Consolidated)

    ROCE (Consolidated) INR Crore FY 21 FY 22 Shareholders' Funds 707.62 783.25 Less : Intangible Assets (Goodwill) (67.67) (67.67) Tangible Net Worth 639.95 715.58 Add : Defferred Tax Liability 11.49 18.63 Add : Total Debt 7.27 0.00 Capital Employed 658.71 734.21 Less : Investments (245.19) (223.15) Ope

  19. Slide 19: Capital Employed (Consolidated)

    Capital Employed (Consolidated) INR Crore Consumerware Scienti c Borosil FY 21 FY 22 FY 21 FY 22 FY 21 FY 22 Working Capital Employed 58.8 92.7 58.7 79.2 117.5 171.9 Working Capital (Days of Sale) 56 59 107 108 73 75 Operating Capital Employed 230.6 297.8 182.9 213.2 413.5 511.0 Operational ROCE 11.

  20. Slide 20: Rationale for Restructuring

    Rationale for Restructuring Both businesses already run as separate pro t centers with largely differentiated teams Both businesses have different capital and operating requirements Different organic and inorganic growth potential and capital raising requirements Each business has a different investor p

  21. Slide 21: Restructuring Process

    Restructuring Process Steps for making effective composite scheme of arrangement Expected Activity Timeline Board approval of the companies involved in the Scheme Completed Submission of Scheme along with supporting documents to BSE & NSE Completed BSE & NSE shall issue an Observation Letter / NOC af

  22. Slide 22: Current Holding Structure

    Current Holding Structure Promoters Public 70.44% 29.56% BL (CP and SIP Business) 82.49% 100% KPL BTL - Borosil Limited ( ‘BL’ or ‘Demerged Company’) (listed on BSE and NSE). - Klass Pack Limited (’KPL’ or Resulting Company / Transferee Company’) is a 82.49% subsidiary of BL. - Borosil Technologies

  23. Slide 23: Resultant Holding Structure

    Resultant Holding Structure Promotors Promoters Public Promotors Promoters Public 70.44% 29.56% 68.16% 31.84% BorosilBL Limited Borosil Scienti BL c Limited (CP (CP andBusiness) SIP Business (CP(SIP andBusiness) SIP Business - It is proposed to demerge SIP business of BL into KPL and in consideratio

  24. Slide 24: Consumer Products Division

    Consumer Products Division Borosil Investor presentation - Q4FY22 22

  25. Slide 25: Borosil Range - Storage, Cooking, and Serving Needs of a Modern Kitchen

    Borosil Range - Storage, Cooking, and Serving Needs of a Modern Kitchen Expanding from being synonymous with microwavable glass to storage, serving-ware, and domestic appliances PREPARE COOK SERVE HEAT STORE Contemporary Everyday Use Performs Beautifully Ally to the progressive homemaker Borosil Inv

  26. Slide 26: Market Opportunity - Consumer Products

    Market Opportunity - Consumer Products Category Market Size - Branded (Crs.) Market Growth % Glass Microwavables 230 10% Tumblers 520 10% Storage 700 15% to 20% Insulated Bottle Range 1100 10% Opalware 900 15% to 20% Tea / Coffee 400 (Incl ceramicware) 15% Domestic Appliances 9000 10% Estimated marke

  27. Slide 27: Consumer Products Division Growth Theme

    Consumer Products Division Growth Theme Made in India - Enhance/ build manufacturing capacity for Opal Glass and Borosilicate Glass New product development To promote Borosil glassware for daily use To make glassware affordable for mass consumers Borosil Investor presentation - Q4FY22 25

  28. Slide 28: Ally Of Progressive Homemaker

    Ally Of Progressive Homemaker #Morning Prep, Chai, Breakfast Appliances Storage 6 AM Dinnerware Cookware #Dinner Prep, Evening Tea, 9 9 #Lunch, PM AM Husband, Kids Dinner Serving Borosil Consumer Pro le: Progressive Homemaker SEC A1-A2 Lunch Box Urban Metro, Mini Metros, A & B Cities Age Group : 25-

  29. Slide 29: Some Key Large Format Store - Trade Partners

    Some Key Large Format Store - Trade Partners Borosil Investor presentation - Q4FY22 27

  30. Slide 30: Some Key Institutional Customers

    Some Key Institutional Customers Borosil Investor presentation - Q4FY22 28

  31. Slide 31: Consumer Products Portfolio - Growth Pillars

    Consumer Products Portfolio - Growth Pillars Core microwavable Larah-Opalware dinnerware: Storage products: products Mass market/daily use Domestic appliances Kitchen & on the go Bring more users Upgrade consumers from Convert from plastics Expand range into category Melamine etc.. Invest in awarene

  32. Slide 32: Larah Opalware - Category Gaining Salience

    Larah Opalware - Category Gaining Salience #2 player in approx. INR 900 cr category Adoption being led by - Gained share - Urbanization and nuclearization of families - Increase in entertaining guests at home Focus on market expansion Capacity expansion - Healthier, economic and aesthetic alternativ

  33. Slide 33: Storage Range - Thoughtful Products Creating A New Pillar of Growth

    Storage Range - Thoughtful Products Creating A New Pillar of Growth Indian kitchen storage dominated by plastic and steel - Very low penetration of glass storage Awareness of glass as a superior option on the rise - No health hazard as in some types of plastic - Transparent as against opaque steel &

  34. Slide 34: Domestic Appliances - New Engine of Growth

    Domestic Appliances - New Engine of Growth - Large market with growth accelerated post Covid - Opportunity to create a high quality mass premium range leveraging the Borosil brand - Commenced without investments in manufacturing assets - Expanding range of product offerings - Increase Made in India p

  35. Slide 35: Consumer Products - Medium-Term Thrust Areas

    Consumer Products - Medium-Term Thrust Areas Achieve revenue CAGR of more than 20% Become brand of consumer choice - Increase penetration of glass storage and Opalware - Maintain investments in brand building - Introduce high-quality & innovative To-Go storage - Introduce new and improved range of p

  36. Slide 36: Scientific Products

    Scienti c Products Borosil Investor presentation - Q4FY22 34

  37. Slide 37: Scientific Products Range

    Scienti c Products Range Laboratory Lab Pharma Glassware Instrumentation Packaging - Volumetric asks - Magnetic Stirrer - Glass Vials - Burettes - Block Digester - Glass Ampoules - Pipettes - Multi-Tube Vortexer - Liquid handling systems Borosil Investor presentation - Q4FY22 35

  38. Slide 38: Market Opportunity - Scientific Products

    Market Opportunity - Scienti c Products Lab Glassware Lab Glassware Lab Pharma Packaging India Exports Instrumentation (Vials & Ampoules) Market size 250 4000 570 1175 (INR Cr.) Estimated market ~8-10% ~2-3% ~8-10% ~10-12% growth Pharma R&D & QC, Pharma R&D, QC Pharma R&D & QC, Pharma companies Cust

  39. Slide 39: Scientific Products Division Growth Theme

    Scienti c Products Division Growth Theme Made in India - Build manufacturing capacity for raw material - tubing production New product development Substantially enhance capacity for ampoules and vials production Borosil Investor presentation - Q4FY22 37

  40. Slide 40: Scientific Products - Some Key Customers

    Scienti c Products - Some Key Customers Borosil Investor presentation - Q4FY22 38

  41. Slide 41: Scientific Products Portfolio - Growth Pillars

    Scienti c Products Portfolio - Growth Pillars Core laboratory LabQuest benchtop Klasspack: primary glass International expansion for glassware instruments packaging for pharma lab glassware industry Steady Business with New product range to New product range to Focus on Middle East, Africa, modest g

  42. Slide 42: Scientific Products: Medium-Term Thrust Areas

    Scienti c Products : Medium-Term Thrust Areas Achieve revenue CAGR of ~15% - Maintain dominant share in pharma lab glassware - Build export market in Lab Glassware & pharma packaging - Drive import substitution in Lab Instrumentation - increase product range - Add new customers & products in vials &

  43. Slide 43: Scientific Products - Laboratory Glassware

    Scienti c Products - Laboratory Glassware Meeting wide product range need of customer - Single supplier convenient for laboratory for multiple critical yet low priced SKUs - Not easily replicable by competition - Reliable supplier for right quality at competitive cost -Expansion into customized lab

  44. Slide 44: Scientific Products - Lab Instrumentation

    Scienti c Products - Lab Instrumentation Portfolio of Lab Essentials, Nutrition & Environment, Life Sciences, analytical Chemistry Leverage existing reach among pharma customers with new products in their existing work ow Build technological advantage through Borosil Technologies with focus on Nutri

  45. Slide 45: Klasspack: Primary Packaging for Pharma

    Klasspack: Primary Packaging for Pharma Glass ampoules & tubular glass vials for packaging pharmaceutical products Applications: Packaging of injectable formulations, ophthalmic, dental products, sample carrier for analytical instruments Provides Borosil’s pharmaceuticals customers credible second a

  46. Slide 46: Our understanding of ESG

    Our understanding of ESG ESG for us is about how we create pro ts. It is outcome driven and not just good intentions. Environment Social Governance - Emissions - Employee health - Risk management Investors - Water and safety system - Energy - Labour practices - Code of conduct - Customer relation -

  47. Slide 47: Borosil 2.0: Leading a responsible tomorrow

    Borosil 2.0: Leading a responsible tomorrow Borosil Limited is on a transformational journey to address key ESG opportunities and create long term value for our customers. Our strategic ESG priorities Our actions in FY22 Social - Plans to undertake GHG monitoring and - Aim to achieve Carbon neutral

  48. Slide 48: Board of Directors

    Board of Directors Pradeep Kumar Kheruka Shreevar Kheruka Rajesh Kumar Chaudhary Chairman Vice Chairman & M.D & CEO Whole Time Director Anupa Rajeev Sahney Kewal Kundanlal Handa Kanwar Bir Singh Anand Naveen Kumar Kshatriya Independent Director Independent Director Independent Director Independent D

  49. Slide 49: Equity Information

    Equity Information No.of Shares issued of Re. 1 each: 11,41,62,667 Share holding pattern 70.44% Promoters 1369812D:IN BOROLTD 26.80% Others 543212 INR 3783 Cr as on - 31 Mar 2022 : 0.05% Other 2.71% Foreign portfolio investors Borosil Investor presentation - Q4FY22 47

  50. Slide 50: Investor Relations Details

    Investors Relations Details Company’s Address Company’s Website Borosil Limited www.borosil.com 1101, Crescenzo, G - Block, www.myborosil.com Opposite MCA Club, Bandra Kurla Complex, Bandra (East), Mumbai - 400 051, India. Investor Relations Anand Sultania, Chief Financial Officer (anand.sultania@bo

  51. Slide 51: Thank You

    Thank You Borosil Investor presentation - Q4FY22 49

Borosil — Q4 FY2022 Earnings Presentation on 6ix